157 related articles for article (PubMed ID: 38156603)
21. Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China.
Li M; Zhao C; Zhao Y; Li J; Wei L
Front Immunol; 2023; 14():1112750. PubMed ID: 36993948
[TBL] [Abstract][Full Text] [Related]
22. Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa.
Tan N; Sharma M; Winer R; Galloway D; Rees H; Barnabas RV
Vaccine; 2018 Aug; 36(32 Pt A):4830-4836. PubMed ID: 29891348
[TBL] [Abstract][Full Text] [Related]
23. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
[TBL] [Abstract][Full Text] [Related]
24. The HPV vaccine: a comparison of focus groups conducted in South Africa and Ohio Appalachia.
Francis SA; Katz ML
Matern Child Health J; 2013 Sep; 17(7):1222-9. PubMed ID: 22930347
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer in Ethiopia: a review of the literature.
Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
[TBL] [Abstract][Full Text] [Related]
26. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
[TBL] [Abstract][Full Text] [Related]
27. Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa.
Michaeli DT; Stoycheva S; Marcus SM; Zhang W; Michaeli JC; Michaeli T
Clin Drug Investig; 2022 Apr; 42(4):333-343. PubMed ID: 35294726
[TBL] [Abstract][Full Text] [Related]
28. Human papilloma virus vaccine for low and middle income countries: A step too soon?
Jindal HA; Kaur A; Murugan S
Hum Vaccin Immunother; 2017 Nov; 13(11):2723-2725. PubMed ID: 28846491
[TBL] [Abstract][Full Text] [Related]
29. Human papilloma virus vaccines and their role in cancer prevention.
Jones RW; Coughlan EP; Reid JS; Sykes P; Watson PD; Cook C
N Z Med J; 2007 Nov; 120(1266):U2829. PubMed ID: 18264198
[TBL] [Abstract][Full Text] [Related]
30. The Vaccine and Cervical Cancer Screen project 2 (VACCS 2): Linking cervical cancer screening to a two-dose HPV vaccination schedule in the South-West District of Tshwane, Gauteng, South Africa.
Snyman LC; Dreyer G; Visser C; Botha MH; van der Merwe FH
S Afr Med J; 2015 Mar; 105(3):191-4. PubMed ID: 26294825
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus vaccination acceptance and hesitancy in South Africa: Research and policy agenda.
Ngcobo NJ; Burnett RJ; Cooper S; Wiysonge CS
S Afr Med J; 2018 Dec; 109(1):13-15. PubMed ID: 30606297
[TBL] [Abstract][Full Text] [Related]
32. Distribution of high- and low-risk human papillomavirus genotypes and their prophylactic vaccination coverage among West African women: systematic review.
Ouedraogo RA; Kande A; Nadembega WMC; Ouermi D; Zohoncon TM; Djigma FW; Ouedraogo CMR; Lompo OM; Simpore J
J Egypt Natl Canc Inst; 2023 Dec; 35(1):39. PubMed ID: 38060078
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer and HPV vaccines in developing countries.
Karimi Zarchi M; Behtash N; Chiti Z; Kargar S
Asian Pac J Cancer Prev; 2009; 10(6):969-74. PubMed ID: 20192568
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer prevention in South Africa: HPV vaccination and screening both essential to achieve and maintain a reduction in incidence.
Botha MH; Richter KL
S Afr Med J; 2015 Jan; 105(1):33-4. PubMed ID: 26046160
[No Abstract] [Full Text] [Related]
35. Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study.
Man I; Georges D; de Carvalho TM; Ray Saraswati L; Bhandari P; Kataria I; Siddiqui M; Muwonge R; Lucas E; Berkhof J; Sankaranarayanan R; Bogaards JA; Basu P; Baussano I
Lancet Oncol; 2022 Nov; 23(11):1419-1429. PubMed ID: 36174583
[TBL] [Abstract][Full Text] [Related]
36. [Screening for cervical cancer, human papillomavirus (HPV) vaccination].
Schaff Z; Járay B
Magy Onkol; 2022 Dec; 66(4):325-330. PubMed ID: 37161827
[TBL] [Abstract][Full Text] [Related]
37. Prevention of cervical cancer.
Denny L
Reprod Health Matters; 2008 Nov; 16(32):18-31. PubMed ID: 19027619
[TBL] [Abstract][Full Text] [Related]
38. Profile of human papillomavirus genotypes in breast and oesophageal cancer patients in Pretoria, South Africa.
Maroga N; Mokoena T; Ledibane N; Musekiwa A; Bida M; Kgomo M; Lebelo R
S Afr Med J; 2023 Jul; 113(7):49-54. PubMed ID: 37882039
[TBL] [Abstract][Full Text] [Related]
39. Africa needs to boost HPV vaccine uptake to stem rise in cervical cancer.
Senior K
Lancet Oncol; 2023 Sep; 24(9):955. PubMed ID: 37517408
[No Abstract] [Full Text] [Related]
40. The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa.
Sinanovic E; Moodley J; Barone MA; Mall S; Cleary S; Harries J
Vaccine; 2009 Oct; 27(44):6196-202. PubMed ID: 19698807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
